{"id":1990,"date":"2017-12-31T00:00:57","date_gmt":"2017-12-30T17:00:57","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=1990"},"modified":"2022-03-30T10:49:15","modified_gmt":"2022-03-30T03:49:15","slug":"phase-iii-clinical-trial-of-ultra-course-rifapentine-isoniazid-for-the-prevention-of-active-tuberculosis-in-hiv-infected-individuals-with-latent-tuberculosis-infection","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/1990\/","title":{"rendered":"A phase 3 clinical trial of ultra-course Rifapentine\/Isoniazid for the prevention of active tuberculosis in HIV-infected individuals with latent tuberculosis infection"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Project no.: <\/strong>A5279 (Short Course Treatment of Latent TB) (NCT01404312)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This study will compare rifapentine plus\nisoniazid daily for 4 weeks to a standard regimen of isoniazid alone daily for\n9 months for the prevention of tuberculosis (TB) in HIV-infected participants\nwho do not show evidence of active TB.&nbsp;&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis study will compare rifapentine plus isoniazid daily for 4 weeks to a standard regimen of isoniazid alone daily for 9 months for the prevention of tuberculosis (TB) in HIV-infected participants who do not show evidence of active TB.  \t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-1990","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=1990"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1990\/revisions"}],"predecessor-version":[{"id":3464,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1990\/revisions\/3464"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=1990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=1990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=1990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}